Neurological Biomarkers Market Report

Global and China Neurological Biomarkers Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 11, 2022
  • PAGES：177
  • REPORT CODE：GMM1454318
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Neurological Biomarkers industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Myriad RBM

    • AbaStar MDx, Inc

    • QIAGEN

    • Alseres Pharmaceuticals, Inc

    • Thermo Fisher Scientific Inc

    • Acumen Pharmaceuticals

    • BANYAN BIOMARKERS, INC

    • Abbott

    • Bio-Rad Laboratories, Inc

    • Athena Diagnostics

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Metabolomic

    • Genomic

    • Proteomic

    • Imaging

    • Others

    Application:

    • Research Organizations

    • Hospital Laboratories

    • Independent Clinical Diagnostic Centers

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Neurological Biomarkers Industry Overview

      • 1.1.1 Neurological Biomarkers Market Scope and Market Segments

      • 1.1.2 Neurological Biomarkers Industry Characteristics

      • 1.1.3 Global and China Neurological Biomarkers Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Neurological Biomarkers Production Value and Growth Rate (2017-2028)

    • 1.2 Global Neurological Biomarkers Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Metabolomic

      • 1.2.2 Genomic

      • 1.2.3 Proteomic

      • 1.2.4 Imaging

      • 1.2.5 Others

    • 1.3 Global Neurological Biomarkers Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Research Organizations

      • 1.3.2 Hospital Laboratories

      • 1.3.3 Independent Clinical Diagnostic Centers

      • 1.3.4 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Neurological Biomarkers Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Neurological Biomarkers Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Neurological Biomarkers Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Neurological Biomarkers Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Neurological Biomarkers Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Neurological Biomarkers Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Neurological Biomarkers Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Neurological Biomarkers Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Neurological Biomarkers Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Neurological Biomarkers Industry Porter's Five Forces Model Analysis

      • 2.2.3 Neurological Biomarkers Industry PEST Analysis

    • 2.3 Neurological Biomarkers Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Neurological Biomarkers Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Neurological Biomarkers Industry

    Chapter 3 Global and China Neurological Biomarkers Market, by Manufacturer

    • 3.1 Global and China Neurological Biomarkers Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Neurological Biomarkers Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Neurological Biomarkers Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Neurological Biomarkers Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Neurological Biomarkers Market Top 3 Players

    Chapter 4 Global and China Neurological Biomarkers Market, by Type (2017-2028)

    • 4.1 Neurological Biomarkers Market Trend, by Type

    • 4.2 Global Neurological Biomarkers Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Neurological Biomarkers Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Neurological Biomarkers Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Neurological Biomarkers Price Trend, by Type (2017-2028)

    • 4.3 China Neurological Biomarkers Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Neurological Biomarkers Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Neurological Biomarkers Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Neurological Biomarkers Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Neurological Biomarkers Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Neurological Biomarkers Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Neurological Biomarkers Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Neurological Biomarkers Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Neurological Biomarkers Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Neurological Biomarkers Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Neurological Biomarkers Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Neurological Biomarkers Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Neurological Biomarkers Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Neurological Biomarkers Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Neurological Biomarkers Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Neurological Biomarkers Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Neurological Biomarkers Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Neurological Biomarkers Market Analysis

    • 7.1 North America Neurological Biomarkers Market, by Type

    • 7.2 North America Neurological Biomarkers Market, by Application

    • 7.3 North America Neurological Biomarkers Market Analysis and Forecast, by Country

      • 7.3.1 United States Neurological Biomarkers Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Neurological Biomarkers Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Neurological Biomarkers Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Neurological Biomarkers Market Analysis

    • 8.1 Europe Neurological Biomarkers Market, by Type

    • 8.2 Europe Neurological Biomarkers Market, by Application

    • 8.3 Europe Neurological Biomarkers Market Analysis and Forecast, by Country

      • 8.3.1 Germany Neurological Biomarkers Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Neurological Biomarkers Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Neurological Biomarkers Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Neurological Biomarkers Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Neurological Biomarkers Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Neurological Biomarkers Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Neurological Biomarkers Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Neurological Biomarkers Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Neurological Biomarkers Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Neurological Biomarkers Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Neurological Biomarkers Market Analysis

    • 9.1 APAC Neurological Biomarkers Market, by Type

    • 9.2 APAC Neurological Biomarkers Market, by Application

    • 9.3 APAC Neurological Biomarkers Market Analysis and Forecast, by Country

      • 9.3.1 China Neurological Biomarkers Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Neurological Biomarkers Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Neurological Biomarkers Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Neurological Biomarkers Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Neurological Biomarkers Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Neurological Biomarkers Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Neurological Biomarkers Market Analysis

    • 10.1 Latin America, Middle East and Africa Neurological Biomarkers Market, by Type

    • 10.2 Latin America, Middle East and Africa Neurological Biomarkers Market, by Application

    • 10.3 Latin America, Middle East and Africa Neurological Biomarkers Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Neurological Biomarkers Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Neurological Biomarkers Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Neurological Biomarkers Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Neurological Biomarkers Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Neurological Biomarkers Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Neurological Biomarkers Company Profiles

      • 11.1 Myriad RBM

        • 11.1.1 Myriad RBM Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Myriad RBM Neurological Biomarkers Product Profiles, Application and Specification

        • 11.1.3 Myriad RBM Neurological Biomarkers Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 AbaStar MDx, Inc

        • 11.2.1 AbaStar MDx, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 AbaStar MDx, Inc Neurological Biomarkers Product Profiles, Application and Specification

        • 11.2.3 AbaStar MDx, Inc Neurological Biomarkers Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 QIAGEN

        • 11.3.1 QIAGEN Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 QIAGEN Neurological Biomarkers Product Profiles, Application and Specification

        • 11.3.3 QIAGEN Neurological Biomarkers Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Alseres Pharmaceuticals, Inc

        • 11.4.1 Alseres Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Alseres Pharmaceuticals, Inc Neurological Biomarkers Product Profiles, Application and Specification

        • 11.4.3 Alseres Pharmaceuticals, Inc Neurological Biomarkers Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Thermo Fisher Scientific Inc

        • 11.5.1 Thermo Fisher Scientific Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Thermo Fisher Scientific Inc Neurological Biomarkers Product Profiles, Application and Specification

        • 11.5.3 Thermo Fisher Scientific Inc Neurological Biomarkers Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Acumen Pharmaceuticals

        • 11.6.1 Acumen Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Acumen Pharmaceuticals Neurological Biomarkers Product Profiles, Application and Specification

        • 11.6.3 Acumen Pharmaceuticals Neurological Biomarkers Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 BANYAN BIOMARKERS, INC

        • 11.7.1 BANYAN BIOMARKERS, INC Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 BANYAN BIOMARKERS, INC Neurological Biomarkers Product Profiles, Application and Specification

        • 11.7.3 BANYAN BIOMARKERS, INC Neurological Biomarkers Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Abbott

        • 11.8.1 Abbott Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Abbott Neurological Biomarkers Product Profiles, Application and Specification

        • 11.8.3 Abbott Neurological Biomarkers Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Bio-Rad Laboratories, Inc

        • 11.9.1 Bio-Rad Laboratories, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Bio-Rad Laboratories, Inc Neurological Biomarkers Product Profiles, Application and Specification

        • 11.9.3 Bio-Rad Laboratories, Inc Neurological Biomarkers Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Athena Diagnostics

        • 11.10.1 Athena Diagnostics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Athena Diagnostics Neurological Biomarkers Product Profiles, Application and Specification

        • 11.10.3 Athena Diagnostics Neurological Biomarkers Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Neurological Biomarkers Industry Investment Prospect and Risk Assessment

    • 12.1 Neurological Biomarkers Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Neurological Biomarkers Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Neurological Biomarkers Sales Volume and Growth Rate (2017-2028)

    • Figure China Neurological Biomarkers Sales Volume and Growth Rate (2017-2028)

    • Figure Global Neurological Biomarkers Production Value and Growth Rate (2017-2028)

    • Figure China Neurological Biomarkers Production Value and Growth Rate (2017-2028)

    • Figure Global Neurological Biomarkers Market Size and Growth Rate of Metabolomic (2017-2028)

    • Figure Global Neurological Biomarkers Market Size and Growth Rate of Genomic (2017-2028)

    • Figure Global Neurological Biomarkers Market Size and Growth Rate of Proteomic (2017-2028)

    • Figure Global Neurological Biomarkers Market Size and Growth Rate of Imaging (2017-2028)

    • Figure Global Neurological Biomarkers Market Size and Growth Rate of Others (2017-2028)

    • Figure Global Neurological Biomarkers Market Size and Growth Rate of Research Organizations (2017-2028)

    • Figure Global Neurological Biomarkers Market Size and Growth Rate of Hospital Laboratories (2017-2028)

    • Figure Global Neurological Biomarkers Market Size and Growth Rate of Independent Clinical Diagnostic Centers (2017-2028)

    • Figure Global Neurological Biomarkers Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Neurological Biomarkers Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Neurological Biomarkers Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Neurological Biomarkers Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Neurological Biomarkers Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Neurological Biomarkers Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Neurological Biomarkers Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Neurological Biomarkers Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Neurological Biomarkers Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Neurological Biomarkers Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Neurological Biomarkers Market Share, by Manufacturer in 2021

    • Figure Global and China Neurological Biomarkers Market Share, by Manufacturer in 2022

    • Table Global Neurological Biomarkers Sales Volume, by Type (2017-2028)

    • Table Global Neurological Biomarkers Sales Volume Share, by Type (2017-2028)

    • Figure Global Neurological Biomarkers Sales Volume Share, by Type (2017-2028)

    • Table Global Neurological Biomarkers Sales Value, by Type (2017-2028)

    • Table Global Neurological Biomarkers Sales Value Share, by Type (2017-2028)

    • Figure Global Neurological Biomarkers Price Trend, by Type (2017-2028)

    • Table China Neurological Biomarkers Sales Volume, by Type (2017-2028)

    • Table China Neurological Biomarkers Sales Volume Share, by Type (2017-2028)

    • Figure China Neurological Biomarkers Sales Volume Share, by Type (2017-2028)

    • Table China Neurological Biomarkers Sales Value, by Type (2017-2028)

    • Table China Neurological Biomarkers Sales Value Share, by Type (2017-2028)

    • Figure China Neurological Biomarkers Price Trend, by Type (2017-2028)

    • Table Global Neurological Biomarkers Sales Volume, by Application (2017-2028)

    • Table Global Neurological Biomarkers Sales Volume Share, by Application (2017-2028)

    • Figure Global Neurological Biomarkers Sales Volume Share, by Application (2017-2028)

    • Table Global Neurological Biomarkers Sales Value, by Application (2017-2028)

    • Table Global Neurological Biomarkers Sales Value Share, by Application (2017-2028)

    • Figure Global Neurological Biomarkers Sales Value Share, by Application (2017-2028)

    • Table China Neurological Biomarkers Sales Volume, by Application (2017-2028)

    • Table China Neurological Biomarkers Sales Volume Share, by Application (2017-2028)

    • Figure China Neurological Biomarkers Sales Volume Share, by Application (2017-2028)

    • Table China Neurological Biomarkers Sales Value, by Application (2017-2028)

    • Table China Neurological Biomarkers Sales Value Share, by Application (2017-2028)

    • Figure China Neurological Biomarkers Sales Value Share, by Application (2017-2028)

    • Figure China Neurological Biomarkers Production, Import, Consumption and Export (2017-2022)

    • Figure North America Neurological Biomarkers Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Neurological Biomarkers Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Neurological Biomarkers Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Neurological Biomarkers Production, Import, Consumption and Export (2017-2022)

    • Table North America Neurological Biomarkers Sales Volume, by Type (2017-2028)

    • Table North America Neurological Biomarkers Sales Volume Share, by Type (2017-2028)

    • Figure North America Neurological Biomarkers Sales Volume Share, by Type (2017-2028)

    • Table North America Neurological Biomarkers Sales Volume, by Application (2017-2028)

    • Table North America Neurological Biomarkers Sales Volume Share, by Application (2017-2028)

    • Figure North America Neurological Biomarkers Sales Volume Share, by Application (2017-2028)

    • Figure United States Neurological Biomarkers Sales Volume and Growth Rate (2017-2028)

    • Figure United States Neurological Biomarkers Sales Value and Growth Rate (2017-2028)

    • Figure Canada Neurological Biomarkers Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Neurological Biomarkers Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Neurological Biomarkers Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Neurological Biomarkers Sales Value and Growth Rate (2017-2028)

    • Table Europe Neurological Biomarkers Sales Volume, by Type (2017-2028)

    • Table Europe Neurological Biomarkers Sales Volume Share, by Type (2017-2028)

    • Figure Europe Neurological Biomarkers Sales Volume Share, by Type (2017-2028)

    • Table Europe Neurological Biomarkers Sales Volume, by Application (2017-2028)

    • Table Europe Neurological Biomarkers Sales Volume Share, by Application (2017-2028)

    • Figure Europe Neurological Biomarkers Sales Volume Share, by Application (2017-2028)

    • Figure Germany Neurological Biomarkers Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Neurological Biomarkers Sales Value and Growth Rate (2017-2028)

    • Figure UK Neurological Biomarkers Sales Volume and Growth Rate (2017-2028)

    • Figure UK Neurological Biomarkers Sales Value and Growth Rate (2017-2028)

    • Figure France Neurological Biomarkers Sales Volume and Growth Rate (2017-2028)

    • Figure France Neurological Biomarkers Sales Value and Growth Rate (2017-2028)

    • Figure Italy Neurological Biomarkers Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Neurological Biomarkers Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Neurological Biomarkers Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Neurological Biomarkers Sales Value and Growth Rate (2017-2028)

    • Figure Spain Neurological Biomarkers Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Neurological Biomarkers Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Neurological Biomarkers Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Neurological Biomarkers Sales Value and Growth Rate (2017-2028)

    • Figure Poland Neurological Biomarkers Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Neurological Biomarkers Sales Value and Growth Rate (2017-2028)

    • Figure Russia Neurological Biomarkers Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Neurological Biomarkers Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Neurological Biomarkers Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Neurological Biomarkers Sales Value and Growth Rate (2017-2028)

    • Table APAC Neurological Biomarkers Sales Volume, by Type (2017-2028)

    • Table APAC Neurological Biomarkers Sales Volume Share, by Type (2017-2028)

    • Figure APAC Neurological Biomarkers Sales Volume Share, by Type (2017-2028)

    • Table APAC Neurological Biomarkers Sales Volume, by Application (2017-2028)

    • Table APAC Neurological Biomarkers Sales Volume Share, by Application (2017-2028)

    • Figure APAC Neurological Biomarkers Sales Volume Share, by Application (2017-2028)

    • Figure China Neurological Biomarkers Sales Volume and Growth Rate (2017-2028)

    • Figure China Neurological Biomarkers Sales Value and Growth Rate (2017-2028)

    • Figure Japan Neurological Biomarkers Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Neurological Biomarkers Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Neurological Biomarkers Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Neurological Biomarkers Sales Value and Growth Rate (2017-2028)

    • Figure India Neurological Biomarkers Sales Volume and Growth Rate (2017-2028)

    • Figure India Neurological Biomarkers Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Neurological Biomarkers Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Neurological Biomarkers Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Neurological Biomarkers Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Neurological Biomarkers Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Neurological Biomarkers Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Neurological Biomarkers Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Neurological Biomarkers Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Neurological Biomarkers Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Neurological Biomarkers Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Neurological Biomarkers Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Neurological Biomarkers Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Neurological Biomarkers Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Neurological Biomarkers Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Neurological Biomarkers Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Neurological Biomarkers Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Neurological Biomarkers Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Neurological Biomarkers Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Neurological Biomarkers Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Neurological Biomarkers Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Neurological Biomarkers Sales Value and Growth Rate (2017-2028)

    • Table Myriad RBM Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Myriad RBM Product Profiles, Application and Specification

    • Table Myriad RBM Neurological Biomarkers Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AbaStar MDx, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AbaStar MDx, Inc Product Profiles, Application and Specification

    • Table AbaStar MDx, Inc Neurological Biomarkers Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table QIAGEN Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table QIAGEN Product Profiles, Application and Specification

    • Table QIAGEN Neurological Biomarkers Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Alseres Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Alseres Pharmaceuticals, Inc Product Profiles, Application and Specification

    • Table Alseres Pharmaceuticals, Inc Neurological Biomarkers Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Thermo Fisher Scientific Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Thermo Fisher Scientific Inc Product Profiles, Application and Specification

    • Table Thermo Fisher Scientific Inc Neurological Biomarkers Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Acumen Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Acumen Pharmaceuticals Product Profiles, Application and Specification

    • Table Acumen Pharmaceuticals Neurological Biomarkers Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table BANYAN BIOMARKERS, INC Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table BANYAN BIOMARKERS, INC Product Profiles, Application and Specification

    • Table BANYAN BIOMARKERS, INC Neurological Biomarkers Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Abbott Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Abbott Product Profiles, Application and Specification

    • Table Abbott Neurological Biomarkers Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bio-Rad Laboratories, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bio-Rad Laboratories, Inc Product Profiles, Application and Specification

    • Table Bio-Rad Laboratories, Inc Neurological Biomarkers Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Athena Diagnostics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Athena Diagnostics Product Profiles, Application and Specification

    • Table Athena Diagnostics Neurological Biomarkers Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US